Leadiant Biosciences Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Leadiant Biosciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013306
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Leadiant Biosciences Inc (Leadiant Biosciences) a subsidiary of Sigma-Tau SpA is a pharmaceutical company that discovers and develops novel medicines. The company offers products such as Cystaran, Carnitor, Matulane, Adagen, Abelcet, DepoCyt, ProXeed Plus, VSL and Colief products. It offers patient support, discovery and development of novel medicines for the unmet needs of patients with rare diseases. The company offers its forms of tablets, oral solution, sugar-free oral solution, capsules and injection. It sells its products through a network of distributors in the US and abroad. Leadiant Biosciences is headquartered in Gaithersburg, Maryland, the US.

Leadiant Biosciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Leadiant Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 11
Licensing Agreements 11
Sigma-Tau Pharma Enters into Licensing Agreement with Crosscare for Colief 11
Soligenix Expands Licensing Agreement With Sigma-Tau Pharma For orBec 12
Equity Offering 14
RegeneRx BioPharma Completes Registered Direct Offering Of US$1.45 Million 14
Asset Transactions 16
Jazz Pharma Acquires Defibrotide from Sigma-Tau Pharma for USD250 Million 16
Acquisition 18
Sigma-Tau May Sell Sigma-Tau Pharma 18
Leadiant Biosciences Inc – Key Competitors 19
Leadiant Biosciences Inc – Key Employees 20
Leadiant Biosciences Inc – Locations And Subsidiaries 21
Head Office 21
Recent Developments 22
Corporate Communications 22
Aug 04, 2016: Sigma-Tau Pharmaceuticals Appoints Michael Minarich as Chief Executive Officer 22
Clinical Trials 23
Jan 03, 2017: First patient enrolled in Registration Studyof Natulan forpatients with advanced Hodgkin’s lymphoma in China 23
Other Significant Developments 24
Feb 28, 2017: Sigma-Tau Pharmaceuticals Changes Name to Leadiant Biosciences And Reaffirms its Commitment to Rare Disease Communities 24
Jun 28, 2016: Sigma-Tau Launching Its Largest VSL3 Patient Savings Program Through Healthcare Professionals 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Leadiant Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Leadiant Biosciences Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Leadiant Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Sigma-Tau Pharma Enters into Licensing Agreement with Crosscare for Colief 11
Soligenix Expands Licensing Agreement With Sigma-Tau Pharma For orBec 12
RegeneRx BioPharma Completes Registered Direct Offering Of US$1.45 Million 14
Jazz Pharma Acquires Defibrotide from Sigma-Tau Pharma for USD250 Million 16
Sigma-Tau May Sell Sigma-Tau Pharma 18
Leadiant Biosciences Inc, Key Competitors 19
Leadiant Biosciences Inc, Key Employees 20

★海外企業調査レポート[Leadiant Biosciences Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cinkarna Celje d.d. Celje (CICG):企業の財務・戦略的SWOT分析
    Cinkarna Celje d.d. Celje (CICG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Aristocrat Leisure Ltd (ALL):企業の財務・戦略的SWOT分析
    Aristocrat Leisure Ltd (ALL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Ceres Power Holdings Plc (CWR):電力:M&Aディール及び事業提携情報
    Summary Ceres Power Holdings Plc (Ceres Power) is an alternative energy company that develops low cost and next generation fuel cell technologies. The company carries out developing steel cell a fuel cell technology that converts natural gas and hydrogen fuel directly into electrical power and heat …
  • Sumitomo Heavy Industries Ltd (6302):企業の財務・戦略的SWOT分析
    Sumitomo Heavy Industries Ltd (6302) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • MISC Berhad:企業の戦略・SWOT・財務分析
    MISC Berhad - Strategy, SWOT and Corporate Finance Report Summary MISC Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Hospitality Properties Trust:企業のM&A・事業提携・投資動向
    Hospitality Properties Trust - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Hospitality Properties Trust Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Dunelm Group plc (DNLM):企業の財務・戦略的SWOT分析
    Dunelm Group plc (DNLM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Zogenix Inc (ZGNX):企業の財務・戦略的SWOT分析
    Zogenix Inc (ZGNX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • The Western Union Company:企業のM&A・事業提携・投資動向
    The Western Union Company - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Western Union Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Hog’s Breath Cafe (Australia) Pty Ltd:企業の戦略・SWOT・財務情報
    Hog's Breath Cafe (Australia) Pty Ltd - Strategy, SWOT and Corporate Finance Report Summary Hog's Breath Cafe (Australia) Pty Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Consolidated Edison Inc (ED):電力:M&Aディール及び事業提携情報
    Summary Consolidated Edison, Inc. (Con Edison) is an investor-owned energy company that offers wide range energy related products and services through its subsidiaries. It operates regulated electricity, gas and steam businesses, and competitive energy businesses. Con Edison’s competitive energy bus …
  • Respiri Ltd (RSH):企業の財務・戦略的SWOT分析
    Respiri Ltd (RSH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Knopp Biosciences LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Knopp Biosciences LLC (Knopp Biosciences) is a drug discovery and development company that offers medicines for the treatment of inflammatory and neurological diseases. The company’s pipeline products include dexpramipexole and KCNQ2. Its dexpramipexole is an anti-inflammatory therapeutic fo …
  • Amcor Ltd:戦略・SWOT・企業財務分析
    Amcor Ltd - Strategy, SWOT and Corporate Finance Report Summary Amcor Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • MDI Achieve Inc-医療機器分野:企業M&A・提携分析
    Summary MDI Achieve Inc (MDI), formerly MDI Technologies Inc is a technology company that designs, develops and commercializes financial and clinical management solutions. The company offers MatrixCare software solutions helps in clinical and resident management, analytics management, financial mana …
  • Visteon Corporation:企業のM&A・事業提携・投資動向
    Visteon Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Visteon Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • OcuNexus Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary OcuNexus Therapeutics Inc (OcuNexus Therapeutics) is a development stage biopharmaceutical company engaged in novel therapeutics for unmet clinical needs in ophthalmology. It has highly differentiated, lead drug candidates based upon a novel mechanism of action such as Gap Junction Channel M …
  • SRT Marine Systems plc (SRT):企業の財務・戦略的SWOT分析
    SRT Marine Systems plc (SRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Central Electricity Generating Co:発電所・企業SWOT分析
    Central Electricity Generating Co - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …
  • TelaDoc Inc (TDOC):医療機器:M&Aディール及び事業提携情報
    Summary TelaDoc Inc (Teladoc) is a provider of telehealth services. The company offers short term prescription for amoxicillin, azithromycin, bactrim DS, augmentin, cipro, tessalon perles, flonase nasal spray, pyridium, prednisone and diflucan. It provides telehealth services for cold and flu sympto …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆